Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleanor Barnes

Showing results (161-170 of 222) with videos related to

Pageof 23
Sort By:
Science Translational Medicine|January 6, 2012
Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple speciesStefano Colloca, Eleanor Barnes, Antonella Folgori, et al.
The Journal of Infection|August 22, 2025
Evaluation of Hepatitis B core-related antigen (HBcrAg) as a biomarker in cohorts from the United Kingdom and South AfricaLouise O Downs, Marion Delphin, Marije van Schalkwyk, et al.
Science (New York, N.Y.)|January 29, 2021
MAIT cell activation augments adenovirus vector vaccine immunogenicityNicholas M Provine, Ali Amini, Lucy C Garner, et al.
Science Translational Medicine|January 6, 2012
Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in manEleanor Barnes, Antonella Folgori, Stefania Capone, et al.
Hepatology (Baltimore, Md.)|October 17, 2015
Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humansChristabel Kelly, Leo Swadling, Stefania Capone, et al.
The Lancet. Gastroenterology & Hepatology|September 1, 2020
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry studyGwilym J Webb, Thomas Marjot, Jonathan A Cook, et al.
Clinical and Experimental Immunology|February 22, 2023
Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccinationSíle A Johnson, Eloise Phillips, Sandra Adele, et al.
Journal of Clinical Microbiology|July 8, 2016
Comparison of Next-Generation Sequencing Technologies for Comprehensive Assessment of Full-Length Hepatitis C Viral GenomesEmma Thomson, Camilla L C Ip, Anjna Badhan, et al.
Elife|September 4, 2019
Interferon lambda 4 impacts the genetic diversity of hepatitis C virusM Azim Ansari, Elihu Aranday-Cortes, Camilla Lc Ip, et al.
British Journal of Haematology|June 13, 2024
Immunogenicity of COVID-19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapyYeong Jer Lim, Victoria Ward, Anthony Brown, et al.
Pageof 23

Showing results (161-170 of 222) with videos related to

Sort By:
Pageof 23
Science Translational Medicine|January 6, 2012
Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple speciesStefano Colloca, Eleanor Barnes, Antonella Folgori, et al.
The Journal of Infection|August 22, 2025
Evaluation of Hepatitis B core-related antigen (HBcrAg) as a biomarker in cohorts from the United Kingdom and South AfricaLouise O Downs, Marion Delphin, Marije van Schalkwyk, et al.
Science (New York, N.Y.)|January 29, 2021
MAIT cell activation augments adenovirus vector vaccine immunogenicityNicholas M Provine, Ali Amini, Lucy C Garner, et al.
Science Translational Medicine|January 6, 2012
Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in manEleanor Barnes, Antonella Folgori, Stefania Capone, et al.
Hepatology (Baltimore, Md.)|October 17, 2015
Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humansChristabel Kelly, Leo Swadling, Stefania Capone, et al.
The Lancet. Gastroenterology & Hepatology|September 1, 2020
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry studyGwilym J Webb, Thomas Marjot, Jonathan A Cook, et al.
Clinical and Experimental Immunology|February 22, 2023
Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccinationSíle A Johnson, Eloise Phillips, Sandra Adele, et al.
Journal of Clinical Microbiology|July 8, 2016
Comparison of Next-Generation Sequencing Technologies for Comprehensive Assessment of Full-Length Hepatitis C Viral GenomesEmma Thomson, Camilla L C Ip, Anjna Badhan, et al.
Elife|September 4, 2019
Interferon lambda 4 impacts the genetic diversity of hepatitis C virusM Azim Ansari, Elihu Aranday-Cortes, Camilla Lc Ip, et al.
British Journal of Haematology|June 13, 2024
Immunogenicity of COVID-19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapyYeong Jer Lim, Victoria Ward, Anthony Brown, et al.
Pageof 23